Osamu Yokosuka is an Emeritus Professor of Chiba University, Japan. He graduated from Chiba University School of Medicine in 1975 then worked as a trainee under Professor K. Okuda in Chiba University Hospital till 1978. Dr. Yokosuka was a research fellow worked under Professor S. Scherlock and Professor B. H. Billing in Royal Free Hospital, London, UK from 1978 to 1980; under Professor M. Omata in Chiba University from 1980 to 1985; and under Dr. J Summers in Fox Chase Cancer Center, PA, USA in 1984. In 1985, he received a Degree of Doctor of Medical Science, and served as an Assistant Professor in Chiba University till 1994, then as Lecturer in Medicine till 2006 when he was appointed as Director and Professor of Medicine. From 2013 to 2015, he served as the Dean of Chiba University School of Medicine.
Dr. Yokosuka was the Secretary General of APASL (2008-2014). In 2016, he was elected as the President of APASL Tokyo, the President of 52nd Annual Meeting of Japan Society of Hepatology, and the President of Funabashi Central Hospital. Dr. Yokosuka’s research mainly focuses on Hepatitis and Hepatocellular Carcinoma. So far, he has published more than 700 original papers.
Tatsuo Kanda received a medical degree in 1991 at Niigata University School of Medicine, Japan, and his PhD in 1999 at Chiba University Graduate School of Medicine, Japan. He had post-doctor training for 3 years under Prof. Ratna Ray and Prof. Ranjit Ray at Saint Louis University, St. Louis, MO, USA. In Dec. 2008, Tatsuo Kanda became a Tenure-track Associate Professor at Department of Medicine and Clinical Oncology, Chiba University, Graduate School of Medicine, Japan. In Feb. 2013, Tatsuo Kanda was nominated a permanent Associate Professor at Department of Gastroenterology and Nephrology, Chiba University, Graduate School of Medicine, Japan. In 2017, Tatsuo Kanda became an Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nihon University School of Medicine. For ~25 years, he has focused his scientific interests on the topics related to liver diseases including acute liver failure, viral hepatitis and autoimmune liver diseases, and worked with Prof. Osamu Yokosuka. Tatsuo Kanda is also an expert for hepatitis A virus (HAV), HBV and HCV, and translation and replication of these viruses, and hepatocarcinogenesis. With his expertise in antiviral therapies and hepatitis virus research, Tatsuo Kanda also sees a lot of patients in clinical daily practice. Tatsuo Kanda has published more than 200 articles in peer-reviewed Journal.
Submission Deadline: August 24, 2018 (Open) Submit Now
Nandini Nair, PhD, MD, FSVM, FACC, FACP
About This Topic
OBM Transplantation publishes peer-reviewed research across the full spectrum of biomedical science, and clinical research and practice in organ transplantation. The journal welcomes experimental, translational and clinical approaches in a special issue directed at Allograft Vasculopathy guest edited by Nandini Nair MD, PhD, FACC, FACP, Texas Tech Health Sciences Center, Lubbock, TX, USA. The journal is seeking original research manuscripts, focused reviews, brief reports, and research letters that address any aspect of allograft vasculopathy, including but not limited to basic mechanisms, epidemiology, pathophysiology, diagnosis, management, and prognosis.
The deadline for submission of manuscripts for consideration for this focus issue is 31st July, 2017. All papers will undergo expedited review with prompt turnaround. All submissions should have a note in the cover letter that they are being submitted for the focus issue.
Please submit manuscripts online via our website. We look forward to receiving your submissions.
Title: Coronary Allograft Vasculopathy-Review of risk factors and pathogenesis
Title: Management of Cardiac Allograft Vasculopathy
Title: Vascular Remodeling in Cardiac Allograft Vasculopathy
Title: Will reducing oxidative stress work in prevention and treatment of Cardiac Allograft Vasculopathy?